Market Overview
The global duck medicine and vaccines market size was valued at USD 1,750 million in 2022 and is projected to reach around USD 3,200 million in 2033 exhibiting a CAGR of 7.5% in the forecasted period. The rising demand of the poultry industry, growing prevalence of diseases of duck, and surging research and development activities are anticipated to boost the market growth. However, high cost involved in the treatment, limited access to the vaccines in developing nations are the factors hindering the growth of the market in the forecasted period.
Report Scope
Report Attributes | Description |
Market Size in 2022 | USD 1,750 Million |
Market Forecast in 2033 | USD 3,200 Million |
CAGR % 2023-2033 | 7.5% |
Base Year | 2022 |
Historic Data | 2019-2021 |
Forecast Period | 2023-2033 |
Report USP | Country and regional analysis, market share data by countries, company investment and key strategies |
Segments Covered | Type and Application |
Regional Scope | North America, Europe, APAC, South America and Middle East and Africa |
Country Scope | U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies |
|
The growing prevalence of viral and bacterial infectious diseases in ducks is anticipated to drive market growth during the forecast period. For instance, as per an article published by Science Direct in September 2021, duck diseases were underreported between 2000 and 2007, but some reports on disease prevalence showed a gradual increase from 2008 to 2015.
Key Companies
· Boehringer Ingelheim International Gmbh
· Ceva
· YEBIO BIOENGINEERING CO., LTD.
· NAVETCO
· Shangqiu Meilan Biological Engineering Co., Ltd.
· Merck & Co., Inc.
· EGAVET
· Bioveta, a.s.
· Jilin Zhengye Biological Products company limited
· Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
· Other players
Moreover, the rising growth plans such as construction of novel labs by the market companies set up in the market to increase the immunizer development is estimated to boost development of the global duck medicine and vaccines market during the anticipated duration. For example, in June 2021, YEBIO BIOENGINEERING CO., LTD developed Yebio High-grade Pathogen Biosafety Grade 3 Labs. This Labs includes working sections such as tissue-level labs and workshops for enormous and normal-sized and small animals, which can be used for pathogen segregation, trial investigations for inhibition and control surveys on illness such as African swine fever and avian influenza.
The coronavirus pandemic has negatively impacted the production, development, and supply of medicines and the growth of the pharmaceutical businesses of several companies across the world. The lockdown has caused in the closure of industrial establishments, excluding the manufacturing of essential supplies and there has been disturbance in the supply chain of pharmaceuticals. Thus, the COVID-19 pandemic has affected the economy in three main ways, by directly affecting the production and demand; by disrupting distribution channels; and by causing financial impact on firms and financial markets. The supply chain and manufacturing activities in China, India, and the U.S. are disturbed due to the global lockdown, while many nations, such as Egypt, Saudi Arabia, the UAE, and others, are facing problems with respect to the transport of drugs from one place to another. Due to all the above reasons, the growth of global duck medicines and vaccines market was adversely hampered.
Type Insights
The vaccines segment led the market for duck medicine and vaccines and accounted for the largest revenue share of around 69% in 2021 over the forecast period, due to the routine vaccinations carried out for the anticipation of diseases in ducks. Diseases such as duck viral hepatitis, duck plague, and others, have no cure available and hence vaccination is the only way to avoid such diseases. For instance, duck viral hepatitis majorly affects ducklings of 2 to 3 weeks of age and there is no treatment option existing and so they can be vaccinated by an attenuated strain of virus before the beginning of egg production.
Application Insights
On the basis of application, the market is segmented into farm and application. In 2021, the farm segment ruled the market for duck medicine and vaccines and held the largest market share of 38%. For instance, as per the data provided by Sentient Media, a non-profit news organization, in January 2022, ducks can work as a vital source for providing eggs or meat in the farms.
Region Insights
North America market dominated the global duck medicine and vaccines market in terms of demand and industry share. This trend can be accredited due to the existence of high number of important industry players as well as the awareness regarding poultry animals in the region. Moreover, the increasing duck farming will boost the growth of the duck medicine and vaccines market in this region.
However, Asia-Pacific is anticipated to grow during the forecasted period owing to increasing duck farm and rising awareness regarding medicines and vaccines for poultry animals in this region.
Key Companies Insights
The market for duck medicine and vaccines is moderately competitive. With the rising applications of duck medicine and vaccines, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the duck medicine and vaccines market, ultimately boosting the market growth. Some of the key companies working in the global duck medicine and vaccines market include:
Some of the Recent Developments:
• In June 2021, YEBIO BIOENGINEERING CO., LTD developed Yebio High-grade Pathogen Biosafety Grade 3 Labs.
• In September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university intending to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks.
Why to buy this Report?
Market research: The report provides valuable insights into market trends, growth opportunities, and competitive landscapes. By reading a technology report, businesses and investors can gain a better understanding of the market they are operating in or considering entering, and make more informed decisions based on data and analysis.
Competitive analysis: The report reports provide detailed information on competitors' strengths, weaknesses, and strategies, which can help businesses identify potential threats and opportunities in the market.
Innovation: The report provides insights into emerging technologies and trends, which can help businesses stay up-to-date with the latest developments and make informed decisions about where to invest their resources.
Due diligence: The report can be used by investors and acquirers as part of their due diligence process when considering investing in or acquiring a technology company. These reports can provide valuable information on the company's financials, technology, market position, and other key factors.
Segments
By Type
• Medicine
• Vaccines
By Application
• Farms
• Applications
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Key FAQ’s
What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue?
• How far market will grow in forecast period in terms of revenue?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar